Chronic low-level lead exposure affects the monoaminergic system in the mouse superior olivary complex

Journal of Comparative Neurology

Volumn 513, Issue 5, 2009, Pages 542-558

  Fortune, Tyler ^a   Lurie, Diana I ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

Auditory; Dopamine hydroxylase; Dorsal raphe; Serotonin; VMAT2

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE BETA MONOOXYGENASE; LEAD; SEROTONIN; SEROTONIN 5; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 2; VESICULAR ACETYLCHOLINE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER; VIAAT PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; AUDITORY SYSTEM; AUTONOMIC INNERVATION; CELL LOSS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEAD BLOOD LEVEL; LONG TERM EXPOSURE; MONOAMINERGIC SYSTEM; MOUSE; NEUROTRANSMISSION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SUPERIOR OLIVARY NUCLEUS; SYNAPSE; WESTERN BLOTTING; ANIMAL; BRAIN STEM; CELL COUNT; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; INFERIOR COLLICULUS; METABOLISM; OLIVARY NUCLEUS;

ANIMALS; BLOTTING, WESTERN; BRAIN STEM; CELL COUNT; DOPAMINE BETA-HYDROXYLASE; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; INFERIOR COLLICULI; LEAD; MICE; OLIVARY NUCLEUS; SEROTONIN; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 64549118640     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21978     Document Type: Article

References (68)

1. Alvarado JC, Fuentes-Santamaria V, Henkel CK, Brunso-Bechtold JK. 2004. Alterations in calretinin immunostaining in the ferret superior olivary complex after cochlear ablation. J Comp Neurol 470:63-79.
2. Baer K, Burli T, Huh KH, Wiesner A, Erb-Vogtli S, Gockeritz-Dujmovic D, Moransard M, Nishimune A, Rees MI, Henley JM, Fritschy JM, Fuhrer C. 2007. PICK1 interacts with alpha7 neuronal nicotinic acetylcholine receptors and controls their clustering. Mol Cell Neurosci 35:339-355.
3. Behrens EG, Schofield BR, Thompson AM. 2002. Aminergic projections to cochlear nucleus via descending auditory pathways. Brain Res 955: 34-44.
4. Berridge CW, Waterhouse BD. 2003. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33-84.
5. Billups B. 2005. Colocalization of vesicular glutamate transporters in the rat superior olivary complex. Neurosci Lett 382:66-70.
6. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. 2006. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 114:1904-1909.
7. Brockel BJ, Cory-Slechta DA. 1998. Lead, attention, and impulsive behavior: changes in a fixed-ratio waiting-for-reward paradigm. Pharmacol Biochem Behav 60:545-552.
8. Caminos E, Garcia-Pino E, Martinez-Galan JR, Juiz JM. 2007. The potassium channel KCNQ5/Kv7.5 is localized in synaptic endings of auditory brainstem nuclei of the rat. J Comp Neurol 505:363-378.
9. Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. 2003a. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348:1517-1526.
10. Canfield RL, Kreher DA, Cornwell C, Henderson CR, Jr. 2003b. Low-level lead exposure, executive functioning, and learning in early childhood. Child Neuropsychol 9:35-53.
11. Chen A, Cai B, Dietrich KN, Radcliffe J, Rogan WJ. 2007. Lead exposure, IQ, and behavior in urban 5- to 7-year-olds: does lead affect behavior only by lowering IQ? Pediatrics 119:e650-658.
12. Chiodo LM, Jacobson SW, Jacobson JL. 2004. Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol 26:359-371.
13. Darrow KN, Maison SF, Liberman MC. 2007. Selective removal of lateral olivocochlear efferents increases vulnerability to acute acoustic injury. J Neurophysiol 97:1775-1785.
14. Devi CB, Reddy GH, Prasanthi RP, Chetty CS, Reddy GR. 2005. Developmental lead exposure alters mitochondrial monoamine oxidase and synaptosomal catecholamine levels in rat brain. Int J Dev Neurosci 23:375-381.
15. Eastwood SL, Harrison PJ. 2001. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55:569-578.
16. Finkelstein Y, Markowitz ME, Rosen JF. 1998. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Brain Res Rev 27:168-176.
17. Fox DA, Kala SV, Hamilton WR, Johnson JE, O'Callaghan JP. 2008. Low-level human equivalent gestational lead exposure produces supernormal scotopic electroretinograms, increased retinal neurogenesis, and decreased retinal dopamine utilization in rats. Environ Health Perspect 116:618-625.
18. Gaspar P, Cases O, Maroteaux L. 2003. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002-1012.
19. Gilbert SG, Weiss B. 2006. A rationale for lowering the blood lead action level from 10 to 2 microg/dL. Neurotoxicology 27:693-701.
20. Glotzer DE, Freedberg KA, Bauchner H. 1995. Management of childhood lead poisoning: clinical impact and cost-effectiveness. Med Decis Making 15:13-24.
21. Gopalakrishnan A, Sievert M, Ruoho AE. 2007. Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe. Mol Pharmacol 72: 1567-1575.
22. Gray L. 1999. Early lead exposure affects auditory temporal processing in chicks. J Environ Med 1:87-93.
23. Hall IC, Hurley LM. 2007. The serotonin releaser fenfluramine alters the auditory responses of inferior colliculus neurons. Hear Res 228:82-94.
24. Hartig W, Stieler J, Boerema AS, Wolf J, Schmidt U, Weissfuss J, Bullmann T, Strijkstra AM, Arendt T. 2007. Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease. Eur J Neurosci 25:69-80.
25. Hurley LM. 2007. Activation of the serotonin 1A receptor alters the temporal characteristics of auditory responses in the inferior colliculus. Brain Res 1181:21-29.
26. Hurley LM, Pollak GD. 1999. Serotonin differentially modulates responses to tones and frequency-modulated sweeps in the inferior colliculus. J Neurosci 19:8071-8082.
27. Hurley LM, Pollak GD. 2005a. Serotonin modulates responses to species-specific vocalizations in the inferior colliculus. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 191:535-546.
28. Hurley LM, Pollak GD. 2005b. Serotonin shifts first-spike latencies of inferior colliculus neurons. J Neurosci 25:7876-7886.
29. Hurley LM, Thompson AM, Pollak GD. 2002. Serotonin in the inferior colliculus. Hear Res 168:1-11.
30. Jaya Prasanthi RP, Hariprasad Reddy G, Bhuvaneswari Devi C, Rajarami Reddy G. 2005. Zinc and calcium reduce lead induced perturbations in the aminergic system of developing brain. Biometals 18:615-626.
31. Jones LG, Prins J, Park S, Walton JP, Luebke AE, Lurie DI. 2008. Lead exposure during development results in increased neurofilament phosphorylation, neuritic beading, and temporal processing deficits within the murine auditory brainstem. J Comp Neurol 506:1003-1017.
32. Kamel NM, Ramadan AM, Kamel MI, Mostafa YA, Abo el-Naga RM, Ali AM. 2003. Impact of lead exposure on health status and scholastic achievement of school pupils in Alexandria. J Egypt Public Health Assoc 78:1-28.
33. Kaushik P, Gorin F, Vali S. 2007. Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. J Comput Neurosci 22:147-160.
34. Klepper A, Herbert H. 1991. Distribution and origin of noradrenergic and serotonergic fibers in the cochlear nucleus and inferior colliculus of the rat. Brain Res 557:190-201.
35. Lanphear BP, Dietrich K, Auinger P, Cox C. 2000. Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep 115:521-529.
36. Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El Mestikawy S, Seif I, Gaspar P. 1996. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17:823-835.
37. Lurie DI, Durham D. 2000. Neuronal death, not axonal degeneration, results in significant gliosis within the cochlear nucleus of adult chickens. Hear Res 149:178-188.
38. Lurie DI, Brooks DM, Gray LC. 2006. The effect of lead on the avian auditory brainstem. Neurotoxicology 27:108-117.
39. Maison SF, Adams JC, Liberman MC. 2003. Olivocochlear innervation in the mouse: immunocytochemical maps, crossed versus uncrossed contributions, and transmitter colocalization. J Comp Neurol 455:406-416.
40. Mannino DM, Albalak R, Grosse S, Repace J. 2003. Second-hand smoke exposure and blood lead levels in U.S. children. Epidemiology 14:719-727.
41. Mannino DM, Homa DM, Matte T, Hernandez-Avila M. 2005. Active and passive smoking and blood lead levels in U.S. adults: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res 7:557-564.
42. Mello CV, Pinaud R, Ribeiro S. 1998. Noradrenergic system of the zebra finch brain: immunocytochemical study of dopamine-betahydroxylase. J Comp Neurol 400:207-228.
43. Mulders WH, Robertson D. 2001. Origin of the noradrenergic innervation of the superior olivary complex in the rat. J Chem Neuroanat 21:313-322.
44. Mulders WH, Robertson D. 2005. Catecholaminergic innervation of guinea pig superior olivary complex. J Chem Neuroanat 30:230-242.
45. Nosjean A, Hamon M, Darmon M. 2002. 5-HT2A receptors are expressed by catecholaminergic neurons in the rat nucleus tractus solitarii. Neuroreport 13:2365-2369.
46. Pan Y, Berman Y, Haberny S, Meller E, Carr KD. 2006. Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nigrostriatal dopamine pathways of chronically food-restricted rats. Brain Res 1122:135-142.
47. Pickles JO. 1976. The noradrenaline-containing innervation of the cochlear nucleus and the detection of signals in noise. Brain Res 105:591-596.
48. Prange O, Wong TP, Gerrow K, Wang YT, El-Husseini A. 2004. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc Natl Acad Sci U S A 101:13915-13920.
49. Sanborn MD, Abelsohn A, Campbell M, Weir E. 2002. Identifying and managing adverse environmental health effects: 3. Lead exposure. Can Med Assoc J 166:1287-1292.
50. Sato K, Shiraishi S, Nakagawa H, Kuriyama H, Altschuler RA. 2000. Diversity and plasticity in amino acid receptor subunits in the rat auditory brain stem. Hear Res 147:137-144.
51. Takamori S, Rhee JS, Rosenmund C, Jahn R. 2000a. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407:189-194.
52. Takamori S, Riedel D, Jahn R. 2000b. Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles. J Neurosci 20:4904-4911.
53. Thompson AM. 2006. "Non-serotonergic" lateral superior olivary neurons of the neonatal mouse contain serotonin. Brain Res 1122:122-125.
54. Thompson AM. 2008. Serotonin immunoreactivity in auditory brainstem neurons of the postnatal monoamine oxidase-A knockout mouse. Brain Res 1228:58-67.
55. Thompson AM, Hurley LM. 2004. Dense serotonergic innervation of principal nuclei of the superior olivary complex in mouse. Neurosci Lett 356:179-182.
56. Tong S, von Schirnding YE, Prapamontol T. 2000. Environmental lead exposure: a public health problem of global dimensions. Bull WHO 78:1068-1077.
57. Toscano CD, Guilarte TR. 2005. Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev 49:529-554.
58. Trussell LO. 2002. Modulation of transmitter release at giant synapses of the auditory system. Curr Opin Neurobiol 12:400-404.
59. Upton AL, Salichon N, Lebrand C, Ravary A, Blakely R, Seif I, Gaspar P. 1999. Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knockout mice: possible role of 5-HT uptake in retinal ganglion cells during development. J Neurosci 19:7007-7024.
60. Wang Q, Woltjer RL, Cimino PJ, Pan C, Montine KS, Zhang J, Montine TJ. 2005. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J 19:869-871.
61. Weihe E, Tao-Cheng JH, Schafer MK, Erickson JD, Eiden LE. 1996. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc Natl Acad Sci U S A 93:3547-3552.
62. Widzowski DV, Cory-Slechta DA. 1994. Homogeneity of regional brain lead concentrations. Neurotoxicology 15:295-307.
63. Wilson MA, Johnston MV, Goldstein GW, Blue ME. 2000. Neonatal lead exposure impairs development of rodent barrel field cortex. Proc Natl Acad Sci U S A 97:5540-5545.
64. Wishcamper CA, Coffin JD, Lurie DI. 2001. Lack of the protein tyrosine phosphatase SHP-1 results in decreased numbers of glia within the motheaten (me/me) mouse brain. J Comp Neurol 441:118-133.
65. Woods CI, Azeredo WJ. 1999. Noradrenergic and serotonergic projections to the superior olive: potential for modulation of olivocochlear neurons. Brain Res 836:9-18.
66. Yao J, Hersh LB. 2007. The vesicular monoamine transporter 2 contains trafficking signals in both its N-glycosylation and C-terminal domains. J Neurochem 100:1387-1396.
67. Yao W, Godfrey DA. 1998. Immunohistochemical evaluation of cholinergic neurons in the rat superior olivary complex. Microsc Res Tech 41:270-283.
68. Zhou M, Hank Simms H, Wang P. 2004. Increased gut-derived norepinephrine release in sepsis: up-regulation of intestinal tyrosine hydroxylase. Biochim Biophys Acta 1689:212-218.